Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
Mora
Circulation 2009;119:2396-2404.
FULL TEXT
Effects of Aspirin When Added to the Prostaglandin D2 Receptor Antagonist Laropiprant on Niacin-Induced Flushing Symptoms
Dishy et al.
J Clin Pharmacol 2009;49:416-422.
ABSTRACT
| FULL TEXT
Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor
Van Linthout et al.
Hypertension 2009;53:682-687.
ABSTRACT
| FULL TEXT
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Mora et al.
Circulation 2009;119:931-939.
ABSTRACT
| FULL TEXT
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Briel et al.
BMJ 2009;338:b92-b92.
ABSTRACT
| FULL TEXT
Standards of Medical Care in Diabetes--2009
American Diabetes Association
Diabetes Care 2009;32:S13-S61.
FULL TEXT
HDL-cholesterol levels and cardiovascular risk: acCETPing the context
Lange and Lindsey
Eur Heart J 2008;29:2708-2709.
FULL TEXT
Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
van der Hoorn et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:2016-2022.
ABSTRACT
| FULL TEXT
Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
Thompson et al.
JAMA 2008;299:2777-2788.
ABSTRACT
| FULL TEXT
The Specific Amino Acid Sequence between Helices 7 and 8 Influences the Binding Specificity of Human Apolipoprotein A-I for High Density Lipoprotein (HDL) Subclasses: A POTENTIAL FOR HDL PREFERENTIAL GENERATION
Carnemolla et al.
J. Biol. Chem. 2008;283:15779-15788.
ABSTRACT
| FULL TEXT
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
J Am Coll Cardiol 2008;51:1512-1524.
FULL TEXT
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Brunzell et al.
Diabetes Care 2008;31:811-822.
FULL TEXT
Association Between Cardiovascular Risk Profiles and the Presence and Extent of Different Types of Coronary Atherosclerotic Plaque as Detected by Multidetector Computed Tomography
Bamberg et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:568-574.
ABSTRACT
| FULL TEXT
Standards of Medical Care in Diabetes--2008
American Diabetes Association
Diabetes Care 2008;31:S12-S54.
FULL TEXT
Effects of Torcetrapib in Patients at High Risk for Coronary Events
Barter et al.
NEJM 2007;357:2109-2122.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein and Dietary Fatty Acids
Kim
JAMA 2007;298:2263-2264.
FULL TEXT
DEBATING CARDIOVASCULAR GOALS
Pokrywka
DOC News 2007;4:5-5.
FULL TEXT